Warrant to Purchase Stock: Greater Bay Venture Banking



 Exhibit 4.27 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH
APPLICABLE LAWS. 
 WARRANT TO PURCHASE STOCK 
  

			
	Corporation:	  	Calix Networks, Inc.
	Number of Shares:	  	18,115
	Class of Stock:	  	Series I Preferred
	Initial Exercise Price:	  	$16.56
	Issue Date:	  	September 4, 2007
	Expiration Date:	  	September 4, 2017

 THIS WARRANT CERTIFIES THAT, in consideration of the payment of $1.00 and for other
good and valuable consideration, Greater Bay Venture Banking, a division of Greater Bay Bank N.A. or its assignee (“Holder”) is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the
“Shares”) of the corporation (the “Company”) at the initial exercise price per Share (the “Warrant Price”) all as set forth above and as adjusted pursuant to Article 2 of this warrant, subject to the provisions and upon
the terms and conditions set forth in this warrant. The Shares shall be Series I Preferred Stock, or such other designation that Company assigns to the capital stock that the Company next sells to institutional investors after the Issue Date, and
the Warrant Price shall be the price per share at which the Company next sells that capital stock. 
 ARTICLE 1. EXERCISE. 
 1.1 Method of Exercise. Holder may exercise this warrant by delivering this warrant and a duly executed Notice of Exercise or Exchange
in substantially the form attached as Appendix 1 to the principal office of the Company. Unless Holder is exercising the exchange right set forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate Warrant Price
for the Shares being purchased. 
 1.2 Net Exercise. In lieu of exercising this warrant as specified in Section 1.1,
Holder may from time to time exchange this warrant, in whole or in part, for a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this warrant minus
the aggregate Warrant Price of such Shares by (b) the fair market value of one Share. The fair market value of the Shares shall be determined pursuant to Section 1.3. 
 1.3 Fair Market Value. For purposes of Section 1.2, fair market value shall be determined as follows: 
 (a) If Holder elects to exchange this Warrant in connection with the Company’s initial public offering and if the Company’s
registration statement relating to such offering has been declared effective by the Securities and Exchange Commission (the “SEC”), the fair market value of the Shares shall be the initial price to the public of the Shares (or the
Company’s stock into which the Shares are convertible) specified in the final prospectus with respect to such offering. 
 (b) If the Shares are traded regularly in a public market, the fair market value of the Shares shall be the closing price of the Shares (or the closing price of the Company’s stock into which the Shares are convertible) reported for
the business day immediately prior to the date Holder delivers its Notice of Exercise or Exchange to the Company. 
 (c) In all
other cases, the Board of Directors of the Company in its reasonable good faith judgment shall determine the fair market value of the Shares (or the Company’s stock into which the Shares are convertible) at the close of business on the business
day immediately prior to the date Holder delivers its Notice of Exercise or Exchange to the Company. If Holder advises the Board of Directors in writing that Holder disagrees with such determination, then the Holder shall promptly select three
independent, nationally recognized investment banking firms and the Company shall select one such firm to determine fair market value. If the fair market value as determined by such investment banking firm is greater than that determined by the
Board of Directors, then all fees










 
and expenses of such investment banking firm shall be paid by the Company. In all other circumstances, such fees and expenses shall be paid by Holder. 
 1.4 Delivery of Certificate and New Warrant. Promptly after Holder exercises or exchanges this warrant, the Company shall deliver to
Holder certificates for the Shares acquired and, if this warrant has not been fully exercised or exchanged and has not expired, a new warrant representing the Shares not so acquired. 
 1.5 Replacement of Warrants. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this warrant and, in the case of loss, theft or destruction, on delivery of an affidavit of loss and indemnity agreement reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on surrender and
cancellation of this warrant, the Company at its expense shall execute and deliver, in lieu of this warrant, a new warrant of like tenor. 
 1.6 Conditional Exercise, Exchange or Sale. Notwithstanding any other provision hereof, the exercise, exchange or sale of this warrant may at the election of the Holder be contingent upon the
Company’s initial public offering or the closing of an Acquisition or other transaction involving the Company, in which case such exercise, exchange or sale shall be deemed to be effective immediately prior to or upon the commencement of the
Company’s initial public offering or the closing of the Acquisition or other transaction involving the Company, as applicable. 
 ARTICLE
2. ADJUSTMENTS TO THE SHARES. 
 2.1 Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on
its common stock payable in common stock or other securities, subdivides the outstanding common stock into a greater amount of common stock, then upon exercise or exchange of this warrant, for each Share acquired, Holder shall receive, without cost
to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record as of the date the dividend or subdivision occurred. 
 2.2 Reclassification, Exchange or Substitution. Upon any reclassification, exchange, substitution, or other event that results in a
change of the number and/or class of the securities issuable upon exercise or conversion of this warrant, Holder shall be entitled to receive, upon exercise or exchange of this warrant, the number and kind of securities and property that Holder
would have received for the Shares if this warrant had been exercised or exchanged immediately before such reclassification, exchange, substitution, or other event. Such an event shall include any automatic conversion of the outstanding or issuable
securities of the Company of the same class or series as the Shares to common stock pursuant to the terms of the Company’s Certificate or Articles of Incorporation upon the closing of a registered public offering of the Company’s common
stock. Upon the closing of any disposition of substantially all of the Company’s assets or a reorganization or merger of the Company, the successor entity shall assume the obligations of this warrant, and the Company or its successor shall
promptly issue to Holder a new warrant for such new securities or other property. The new warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including,
without limitation, adjustments to the Warrant Price and to the number of securities or property issuable upon exercise of the new warrant. The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges,
substitutions, or other events. 
 2.3 Adjustments for Combinations, Etc. If the outstanding Shares are combined or
consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased. 
 2.4 No Impairment. The Company shall not, by amendment of its Certificate or Articles of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this warrant by the Company, but shall at all times in good faith assist in carrying out all the provisions of this Article
2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. Notwithstanding the foregoing, the Company shall not be deemed to have impaired Holder’s rights if it
amends its Certificate of Incorporation or stockholders agreements or the holders of the Company’s preferred stock waive any of their rights thereunder, in a manner that does not affect Holder in a manner materially different from the effect
that such amendments or waivers have generally on the rights of the holders of the Company’s preferred stock. If the Company takes any action affecting the Shares or

  

 2 








 
its common stock other than as described above that adversely affects Holder’s rights under this warrant, the Warrant Price shall be adjusted downward and the number of Shares issuable upon
exercise of this warrant shall be adjusted upward in such a manner that the aggregate Warrant Price of this warrant is unchanged. 
 2.5 Certificate as to Adjustments. Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer setting forth such
adjustment and the facts upon which such adjustment is based. The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant
Price. 
 ARTICLE 3. REPRESENTATIONS AND COVENANTS. 
 3.1 Representations and Warranties of the Company. The Company hereby represents and warrants to the Holder as follows: 
 (a) The initial Warrant Price referenced on the first page of this warrant is not greater than the fair market value of the Shares as of the
date of this warrant. 
 (b) All Shares which may be issued upon the exercise or exchange of this warrant, and all securities,
if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under
applicable federal and state securities laws. 
 (c) The Company’s capitalization table attached to this warrant is true
and complete. 
 3.2 Notice of Certain Events. If the Company proposes at any time (a) to declare any dividend or
distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its stock any additional
shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; or (d) to merge or consolidate with or into any other corporation, or sell, lease, license, or convey all or
substantially all of its assets, or to liquidate, dissolve or wind up, then, in connection with each such event, the Company shall give Holder (1) at least 20 days prior written notice of the date on which a record will be taken for such
dividend, distribution, or subscription rights (and specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (a) and (b) above;
and (2) in the case of the matters referred to in (c) and (d) above at least 20 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common stock will be entitled to
exchange their common stock for securities or other property deliverable upon the occurrence of such event). 
 3.3
Information Rights. So long as the Holder holds this warrant and/or any of the Shares, the Company shall deliver to the Holder (a) promptly after mailing, copies of all communiques to the shareholders of the Company, (b) within 120
days after the end of each fiscal year of the Company, the annual audited financial statements of the Company certified by independent public accountants of recognized standing and (c) within 45 days after the end of each of the first three
quarters of each fiscal year, the Company’s quarterly, unaudited financial statements. 
 3.4 Reservation of Shares.
The Company shall at all times reserve and keep available out of its authorized but unissued capital stock, solely for the purpose of issuance upon the exercise or exchange of this warrant, the maximum number of Shares issuable upon exercise of this
warrant (and shares issuable, directly or indirectly, upon conversion of the Shares, if any). 
 ARTICLE 4. MISCELLANEOUS. 
 4.1 Registration Rights. The common stock into which the Shares are convertible shall be deemed “Registrable Securities” and
Holder shall have the rights of a “Holder” under that certain Amended and

  

 3 








 
Restated Investors’ Rights Agreement, dated June 22, 2007, (the “Rights Agreement”) between the Company and its investor(s) in the form presented to
Holder as of the Issue Date. 
 4.2 Term. This warrant is exercisable in whole or in part, at any time and from time to
time on or before the Expiration Date set forth above. If this warrant has not been exercised prior to the Expiration Date, this warrant shall be deemed to have been automatically exchanged on the Expiration Date for shares pursuant to
Section 1.2. 
 4.3 Legends. This warrant and the Shares (and the securities issuable, directly or indirectly, upon
conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form: 
 THIS SECURITY HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAWS. 
 4.4 Compliance with Securities Laws on Transfer. This warrant and the Shares issuable upon exercise of this warrant (and the securities issuable, directly or indirectly, upon conversion of the
Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee (including, without limitation, the delivery of investment
representation letters and legal opinions reasonably acceptable to the Company, as reasonably requested by the Company). 
 4.5
Transfer Procedure. Subject to the provisions of Section 4.3, Holder may transfer all or part of this warrant or the Shares issuable upon exercise of this warrant (or the securities issuable, directly or indirectly, upon conversion of
the Shares, if any) by giving the Company notice of the portion of the warrant being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this warrant to the Company for reissuance to the
transferee(s) (and Holder, if applicable); provided, however, that Holder may transfer all or part of this warrant to its affiliates at any time without notice to the Company, and such affiliate shall then be entitled to all the rights of
Holder under this warrant and any related agreements, and the Company shall cooperate fully in ensuring that any stock issued upon exercise of this warrant is issued in the name of the affiliate that exercises the warrant. The terms and conditions
of this warrant shall inure to the benefit of, and be binding upon, the Company and the holders hereof and their respective permitted successors and assigns. 
 4.6 Notices. All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally or mailed by first-class registered or
certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as the case may be, in writing by the Company or such Holder from time to time. All notices to the Holder shall be addressed as follows:

 Greater Bay Venture Banking, a division of Greater Bay Bank N.A. 
      
      
      
 4.7 Waiver. This warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed
by the party against which enforcement of such change, waiver, discharge or termination is sought. 
 4.8 Attorneys’
Fees. In the event of any dispute between the parties concerning the terms and provisions of this warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including
reasonable attorneys’ fees. 
 4.9 Governing Law. This warrant shall be governed by and construed in accordance with
the laws of the State of California, without giving effect to its principles regarding conflicts of law. 
  

 4 








 The Company has caused this warrant to be duly executed and delivered as of the Issue Date
specified above. 
  

			
	Calix Networks, Inc.
		
	By: 	 	/s/ Michael F. Ashby
	Name:	 	Michael F. Ashby
	Title:	 	Chief Financial Officer











 APPENDIX 1 
 NOTICE OF EXERCISE 
 1. The undersigned hereby elects to (check applicable
blank below): 
  

	 	_____	purchase ______________ Shares of the Series I Preferred stock of Calix Networks, Inc. pursuant to the terms of the attached warrant, and tenders herewith
payment of the Warrant Price of such Shares in full; or 

  

	 	_____	exchange the attached warrant for Shares in the manner specified in the warrant. This exchange is exercised with respect to ______________ of the Shares covered by the
warrant. 

 2. Please issue a certificate or certificates representing said shares in the name of the undersigned
or in such other name as is specified below: 
  

							
	 	 		 		 	
	Attn:                                      
       	 		 		 	
				
	 	 		 		 	
				
	 	 		 		 	
				
	Or Registered Assignee	 		 		 	

 3. The undersigned represents it is acquiring the Shares solely for its own account
and not as a nominee for any other party and not with a view toward the resale or distribution thereof except in compliance with applicable securities laws. 
                  or Registered Assignee 
  

	
	
	  
	(Signature)
	
	  
	(Date)